Intelligent Bio Solutions (NASDAQ:INBS) Trading Down 11%

Intelligent Bio Solutions Inc. (NASDAQ:INBSGet Free Report)’s stock price fell 11% during mid-day trading on Tuesday . The stock traded as low as $0.20 and last traded at $0.21. 495,781 shares were traded during mid-day trading, an increase of 123% from the average session volume of 222,501 shares. The stock had previously closed at $0.24.

Intelligent Bio Solutions Stock Down 11.0 %

The company has a debt-to-equity ratio of 0.11, a current ratio of 0.66 and a quick ratio of 0.49. The stock has a 50-day moving average price of $0.83 and a 200-day moving average price of $1.94.

Intelligent Bio Solutions (NASDAQ:INBSGet Free Report) last posted its quarterly earnings results on Thursday, August 24th. The company reported ($1.91) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.66) by ($0.25). The company had revenue of $0.44 million during the quarter, compared to analyst estimates of $0.49 million. As a group, equities research analysts anticipate that Intelligent Bio Solutions Inc. will post -3.44 earnings per share for the current fiscal year.

Institutional Trading of Intelligent Bio Solutions

A hedge fund recently bought a new stake in Intelligent Bio Solutions stock. Sabby Management LLC acquired a new position in shares of Intelligent Bio Solutions Inc. (NASDAQ:INBSFree Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 126,650 shares of the company’s stock, valued at approximately $367,000. Intelligent Bio Solutions comprises 0.3% of Sabby Management LLC’s portfolio, making the stock its 26th largest holding. Sabby Management LLC owned 8.52% of Intelligent Bio Solutions at the end of the most recent quarter. Institutional investors and hedge funds own 9.28% of the company’s stock.

Intelligent Bio Solutions Company Profile

(Get Free Report)

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.

Featured Stories

Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.